Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rumex crispus, commonly known as Curly Dock or Yellow Dock, is a perennial flowering plant native to Europe and Western Asia, belonging to the Polygonaceae family. Various parts of the plant, particularly the root, are widely utilized in traditional herbal medicine and as dietary supplements. Its therapeutic properties are attributed to a diverse array of bioactive compounds, including anthraquinones (such as emodin, chrysophanol, and physcion), flavonoids (like quercetin and kaempferol), tannins, and oxalic acid. Traditionally, it is recognized for its laxative, anti-inflammatory, antioxidant, antimicrobial, and detoxifying actions. It is also employed for addressing skin conditions, digestive complaints, supporting liver function, and enhancing iron absorption. Research indicates potential roles in inhibiting osteoclastogenesis, inducing osteoblast mineralization, and exhibiting antiproliferative effects against certain cancer cell lines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rumex crispus.